These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6178690)

  • 1. Pathogenesis of herpes simplex labialis: correlation of vesicle fluid interferon with lesion age and virus titer.
    Spruance SL; Green JA; Chiu G; Yeh TJ; Wenerstrom G; Overall JC
    Infect Immun; 1982 Jun; 36(3):907-10. PubMed ID: 6178690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis of recurrent herpes simplex labialis. IV. Maturation of lesions within 8 hours after onset and implications for antiviral treatment.
    Spruance SL; Wenerstrom G
    Oral Surg Oral Med Oral Pathol; 1984 Dec; 58(6):667-71. PubMed ID: 6095159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral-induced leukocyte interferon in vesicle fluid from lesions of recurrent herpes labialis.
    Overall JC; Spruance SL; Green JA
    J Infect Dis; 1981 Apr; 143(4):543-7. PubMed ID: 6165784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The natural history of recurrent herpes simplex labialis: implications for antiviral therapy.
    Spruance SL; Overall JC; Kern ER; Krueger GG; Pliam V; Miller W
    N Engl J Med; 1977 Jul; 297(2):69-75. PubMed ID: 194157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune response to herpes simplex virus in patients with recurrent herpes labialis. II. Relationship between interferon production and cytotoxic responses.
    Tsutsumi H; Bernstein JM; Riepenhoff-Talty M; Ogra PL
    Pediatr Res; 1986 Sep; 20(9):905-8. PubMed ID: 3018660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural history of frequent recurrences of herpes simplex labialis.
    Davis LE; Redman JC; Skipper BJ; McLaren LC
    Oral Surg Oral Med Oral Pathol; 1988 Nov; 66(5):558-61. PubMed ID: 3200559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta interferon produced by keratinocytes in human cutaneous infection with herpes simplex virus.
    Torseth JW; Nickoloff BJ; Basham TY; Merigan TC
    J Infect Dis; 1987 Apr; 155(4):641-8. PubMed ID: 2434580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Penciclovir cream for the treatment of sunlight-induced herpes simplex labialis: a randomized, double-blind, placebo-controlled trial. Penciclovir Cream Herpes Labialis Study Group.
    Boon R; Goodman JJ; Martinez J; Marks GL; Gamble M; Welch C
    Clin Ther; 2000 Jan; 22(1):76-90. PubMed ID: 10688392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Penciclovir cream for the treatment of herpes simplex labialis. A randomized, multicenter, double-blind, placebo-controlled trial. Topical Penciclovir Collaborative Study Group.
    Spruance SL; Rea TL; Thoming C; Tucker R; Saltzman R; Boon R
    JAMA; 1997 May; 277(17):1374-9. PubMed ID: 9134943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent herpes simplex labialis: viral replication and clinical course.
    Rytel MW; Niebojewski RA; Aguilar-Torres FG; Russell TJ
    Am J Med Sci; 1978; 276(3):319-23. PubMed ID: 217269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. gamma Interferon production appears to predict time of recurrence of herpes labialis.
    Cunningham AL; Merigan TC
    J Immunol; 1983 May; 130(5):2397-400. PubMed ID: 6403619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human herpes simplex labialis.
    Fatahzadeh M; Schwartz RA
    Clin Exp Dermatol; 2007 Nov; 32(6):625-30. PubMed ID: 17953630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Th1/Th2-like immunity and resistance to herpes simplex labialis.
    Spruance SL; Evans TG; McKeough MB; Thai L; Araneo BA; Daynes RA; Mishkin EM; Abramovitz AS
    Antiviral Res; 1995 Sep; 28(1):39-55. PubMed ID: 8585759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-lambda in immunocompetent individuals with a history of recurrent herpes labialis.
    Pica F; Volpi A; Gaziano R; Garaci E
    Antivir Ther; 2010; 15(5):737-43. PubMed ID: 20710055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early, patient-initiated treatment of herpes labialis with topical 10% acyclovir.
    Spruance SL; Crumpacker CS; Schnipper LE; Kern ER; Marlowe S; Arndt KA; Overall JC
    Antimicrob Agents Chemother; 1984 May; 25(5):553-5. PubMed ID: 6732224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spontaneous and induced interferon production by peripheral blood mononuclear leukocytes from humans with herpes labialis.
    Green JA; Weiss PN; Spruance SL
    J Immunol; 1983 Dec; 131(6):2827-9. PubMed ID: 6196402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shedding of infectious virus/antibody complexes from vesicular lesions of patients with recurrent herpes labialis.
    Daniels CA; LeGoff SG
    Lancet; 1975 Sep; 2(7934):524-8. PubMed ID: 51344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Herpes simplex virus 1 and herpes labialis].
    Cumbo V; Gallina G; Messina P
    Stomatol Mediterr; 1986; 6(2):171-85. PubMed ID: 3022404
    [No Abstract]   [Full Text] [Related]  

  • 19. Pathogenesis of herpes simplex labialis: excretion of virus in the oral cavity.
    Spruance SL
    J Clin Microbiol; 1984 May; 19(5):675-9. PubMed ID: 6330166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic chemotherapy with acyclovir for recurrent herpes simplex labialis.
    Spruance SL
    J Med Virol; 1993; Suppl 1():27-32. PubMed ID: 8245889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.